Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer

Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer

BackgroundTriple-negative breast cancer (TNBC) is a highly aggressive cancer with poor prognosis. The lack of effective targeted therapies for TNBC remains a profound clinical challenge. Fusion transcripts play critical roles in carcinogenesis and serve as valuable diagnostic and therapeutic targets...

Full description

Bibliographic Details
Main Authors: Meng-Yuan Wang, Man Huang, Chao-Yi Wang, Xiao-Ying Tang, Jian-Gen Wang, Yong-De Yang, Xin Xiong, Chao-Wei Gao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
triple-negative breast cancer
MFGE8-HAPLN3
biomarker
target
precision treatment
fusion
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.682021/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.682021/full

Similar Items